Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-12-13
2005-12-13
Witz, Jean C. (Department: 1651)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C435S219000, C435S236000
Reexamination Certificate
active
06974792
ABSTRACT:
A native, chromatographically purified α1-AT preparation having a purity of at least 0.7 PU/mg protein and a relative plasma α1-AT activity of at least 120% is disclosed. The ratio of active to inactive α1-AT is higher than in plasma.Furthermore, a method of producing this preparation is disclosed, as well as the use of a carrier material, e.g. an inorganic carrier material such as hydroxylapatite for separating active α1-AT from inactive α1-AT.
REFERENCES:
patent: 5610285 (1997-03-01), Lebing et al.
patent: 5760179 (1998-06-01), Fitchmun
Product Information for CHT Cermain Hydroxyapatitle and Bio-gel Hydroxyapatite from the website: http://bio-rad.com/B2B/BioRad/product/br—categoy.
Chan et al. “Purification and Chemical Composition of Human alpha 1-Antitrypsin of the MM Type” FEBS Lett. (1973) 35(1): 79-82.
Mattes Erwin
Matthiessen H. Peter
Baxter Aktiengesellschaft
Eagleman Patrick S.
Hanley Susan
Witz Jean C.
LandOfFree
Alpha 1-antitrypsin preparation as well as a method for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alpha 1-antitrypsin preparation as well as a method for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha 1-antitrypsin preparation as well as a method for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3475198